At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
Light therapy A via the Re-Timer® +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Morning Light Treatment for Traumatic Stress: The Role of Amygdala Reactivity
In Brief
A clinical study evaluating Light therapy A via the Re-Timer®, Light therapy B via the Re-Timer®, and 1 other intervention for Stress. Completed, enrolled 50 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the effect of different amounts of time of morning light on brain emotional processing.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStress
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedOct 2019
Enrollment StartJan 2020
Primary CompletionMar 2023
TodayJul 2026
First PostedOct 7, 2019
Enrollment StartJan 24, 2020
Primary CompletionMar 8, 2023
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 6.7 years ago
Interventions
Light therapy A via the Re-Timer®device
Subjects will conduct light treatment in the mornings at home.
Light therapy B via the Re-Timer®device
Subjects will conduct light treatment in the mornings at home.
Light therapy C via the Re-Timer®device
Subjects will conduct light treatment in the mornings at home.